Company intelligence / Profile preview

Candor

Wangen im Allgäu, Baden-Württemberg, Germany

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Candor Bioscience is a German life science company specializing in the development and manufacturing of high-quality solutions for immunoassays. The company provides a comprehensive range of stabilizers, blockers, and buffers designed to improve the reliability and precision of assays such as ELISA, Western blotting, and immunohistochemistry. Their flagship product, LowCross-Buffer, is widely used to minimize interference and matrix effects in complex samples. Candor also offers contract research services for assay development and optimization to pharmaceutical and diagnostic partners.

Modalities: Immunoassay ReagentsDiagnostic Tools
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Candor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Candor.

Explore the full profile